Largest pharmaceutical companies in the United States by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 44 pharmaceutical companies in the United States ranked by total assets, at ZAR 3.64T, ahead of Johnson & Johnson (ZAR 3.48T) and Merck & Co (ZAR 2.39T). Figures as of 20 Nov 2026, 12:36 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- PfizerZAR 3.64T
- Median
- ZAR 26.1B
- Combined market value
- ZAR 65.28T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | ZAR 3.64T | ZAR 2.74T | ZAR 481.23 | 1.85% down | 10% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | ZAR 3.48T | ZAR 11.24T | ZAR 4,668.00 | 2.04% down | 31% up | ||
| 3 | Merck & CoMRK · Health Care | ZAR 2.39T | ZAR 5.72T | ZAR 2,320.72 | 3.61% down | 36% up | ||
| 4 | AbbVieABBV · Health Care | ZAR 2.34T | ZAR 8.76T | ZAR 4,954.57 | 0.86% down | 20% up | ||
| 5 | Eli LillyLLY · Health Care | ZAR 1.97T | ZAR 21.03T | ZAR 23,609.43 | 2.29% down | 28% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | ZAR 1.57T | ZAR 2.08T | ZAR 1,019.43 | 2.05% down | 26% up | ||
| 7 | Abbott LaboratoriesABT · Health Care | ZAR 1.52T | ZAR 3.14T | ZAR 1,815.02 | 0.58% down | 19% down | ||
| 8 | Regeneron PharmaceuticalsREGN · Health Care | ZAR 708.7B | ZAR 1.67T | ZAR 16,134.42 | 2.35% down | 22% up | ||
| 9 | ViatrisVTRS · Health Care | ZAR 649.9B | ZAR 398.3B | ZAR 347.38 | 1.97% down | 90% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | ZAR 448.1B | ZAR 2.31T | ZAR 9,098.00 | 2.94% down | 22% up | ||
| 11 | Royalty PharmaRPRX · Health Care | ZAR 342.9B | ZAR 680.4B | ZAR 1,183.34 | 1.38% down | 74% up | ||
| 12 | ZoetisZTS · Health Care | ZAR 270.3B | ZAR 573.6B | ZAR 1,411.72 | 5.59% down | 34% down | ||
| 13 | Elanco Animal HealthELAN · Health Care | ZAR 233.4B | ZAR 229.6B | ZAR 459.39 | 1.54% down | 18% up | ||
| 14 | United TherapeuticsUTHR · Health Care | ZAR 137.7B | ZAR 416.1B | ZAR 9,769.70 | 3.16% down | 18% up | ||
| 15 | BioMarin PharmaceuticalBMRN · Health Care | ZAR 132.7B | ZAR 207.9B | ZAR 1,073.25 | 0.02% down | 12% up | ||
| 16 | Alnylam PharmaceuticalsALNY · Health Care | ZAR 86.8B | ZAR 346B | ZAR 2,583.00 | 1.06% down | 66% down | ||
| 17 | Amneal PharmaceuticalsAMRX · Health Care | ZAR 64.3B | ZAR 130.2B | ZAR 373.77 | 2.24% down | 79% up | ||
| 18 | Ionis PharmaceuticalsIONS · Health Care | ZAR 61.6B | ZAR 79.2B | ZAR 475.64 | 0.62% down | 64% down | ||
| 19 | PTC TherapeuticsPTCT · Health Care | ZAR 50.7B | ZAR 85.1B | ZAR 1,019.17 | 3.16% down | 26% down | ||
| 20 | InsmedINSM · Health Care | ZAR 39.6B | ZAR 553.8B | ZAR 2,524.29 | 20.58% up | 27% down | ||
| 21 | Legend BiotechLEGN · Health Care | ZAR 30.3B | ZAR 54.6B | ZAR 281.33 | 0.92% down | 43% down | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | ZAR 27.3B | ZAR 100.3B | ZAR 5,013.98 | 3.94% down | 44% up | ||
| 23 | CytokineticsCYTK · Health Care | ZAR 24.9B | ZAR 125.3B | ZAR 899.21 | 0.27% up | 21% down | ||
| 24 | Arrowhead PharmaceuticalsARWR · Health Care | ZAR 24.2B | ZAR 107.8B | ZAR 762.74 | 1.25% up | 8% up | ||
| 25 | Madrigal PharmaceuticalsMDGL · Health Care | ZAR 22B | ZAR 161B | ZAR 6,932.62 | 0.34% down | 28% down | ||
| 26 | TG TherapeuticsTGTX · Health Care | ZAR 18.6B | ZAR 171.4B | ZAR 1,133.71 | 1.88% down | 103% up | ||
| 27 | Praxis Precision MedicinesPRAX · Health Care | ZAR 16.4B | ZAR 151.9B | ZAR 5,432.66 | 1.87% up | 83% up | ||
| 28 | Cogent BiosciencesCOGT · Health Care | ZAR 16.4B | ZAR 84.3B | ZAR 484.73 | 0.25% down | 25% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | ZAR 16.4B | ZAR 266.1B | ZAR 1,366.11 | 0.22% up | 15% up | ||
| 30 | Mirum PharmaceuticalsMIRM · Health Care | ZAR 14.7B | ZAR 109B | ZAR 1,668.94 | 3.27% up | 35% up | ||
| 31 | Corcept TherapeuticsCORT · Health Care | ZAR 14.6B | ZAR 124.3B | ZAR 1,135.46 | 4.15% down | 16% down | ||
| 32 | Belite BioBLTE · Health Care | ZAR 13.6B | ZAR 107.2B | ZAR 2,638.92 | 3.33% down | 25% up | ||
| 33 | Spyre TherapeuticsSYRE · Health Care | ZAR 13.6B | ZAR 162B | ZAR 1,705.98 | 3.77% down | 302% up | ||
| 34 | Summit TherapeuticsSMMT · Health Care | ZAR 13.1B | ZAR 147.7B | ZAR 184.70 | 0.67% up | 35% down | ||
| 35 | Axsome TherapeuticsAXSM · Health Care | ZAR 12.1B | ZAR 124.7B | ZAR 2,370.87 | 1.25% up | 9% down | ||
| 36 | Protagonist TherapeuticsPTGX · Health Care | ZAR 11.7B | ZAR 141.4B | ZAR 2,167.12 | 2.47% down | 45% up | ||
| 37 | Travere TherapeuticsTVTX · Health Care | ZAR 10.6B | ZAR 81B | ZAR 843.99 | 3.86% down | 39% up | ||
| 38 | Edgewise TherapeuticsEWTX · Health Care | ZAR 9.7B | ZAR 78.8B | ZAR 719.40 | 0.48% down | 82% up | ||
| 39 | Dianthus TherapeuticsDNTH · Health Care | ZAR 9.3B | ZAR 83.5B | ZAR 1,482.32 | 1.01% up | 105% up | ||
| 40 | Oruka TherapeuticsORKA · Health Care | ZAR 8.5B | ZAR 115.6B | ZAR 1,704.94 | 1.91% up | 233% up | ||
| 41 | Rhythm PharmaceuticalsRYTM · Health Care | ZAR 8.4B | ZAR 141.5B | ZAR 2,040.96 | 1.88% down | 15% up | ||
| 42 | Definium TherapeuticsDFTX · Health Care | ZAR 7.7B | ZAR 70.5B | ZAR 515.13 | 1.24% up | 176% up | ||
| 43 | ErascaERAS · Health Care | ZAR 6.9B | ZAR 87.2B | ZAR 248.48 | 3.34% up | 387% up | ||
| 44 | VeradermicsMANE · Health Care | ZAR 2.7B | ZAR 91.7B | ZAR 2,173.59 | 0.38% down | 230% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.4740 ZAR).
Questions and answers
Which pharmaceutical companies in the United States rank first by total assets?
Pfizer (ZAR 3.64T), Johnson & Johnson (ZAR 3.48T) and Merck & Co (ZAR 2.39T) are the top three of the 44 pharmaceutical companies in the United States ranked by total assets as of 20 Nov 2026, 12:36 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by total assets.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by total assets have a combined market value of ZAR 65.28T as of 20 Nov 2026, 12:36 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by total assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.